SCHEMBL13879148

SCHEMBL13879148

O=C1C(Oc2cc(C(F)(F)F)cc(C(F)(F)F)c2)=C(Oc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NSD2 O96028 1/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ HKDC1 Q2TB90 1/20 0.43
▸ TLR9 Q9NR96 1/20 0.43
▸ TLR8 Q9NR97 2/20 0.42
▸ MAOB P27338 2/20 0.41
▸ ADORA2A P29274 1/20 0.40
▸ TP53 P04637 2/20 0.39
▸ CDC25B P30305 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MAP2K7 O14733 1/20 0.39
▸ GMNN O75496 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13879152 0.86 KIF11 (0.50) NSD2HSP90AA1HKDC1TLR9MAOB
SCHEMBL13879151 0.84 NSD2 (0.49) NSD2HSP90AA1HKDC1TLR9MAOB
SCHEMBL17594744 0.76 NSD2 (0.47) NSD2HSP90AA1HKDC1TLR9TP53
SCHEMBL29723532 0.75 LTA4H (0.52) TLR8MAOBALDH1A1CYP1A2MAPT
SCHEMBL1804265 0.73 NSD2 (0.49) NSD2HSP90AA1HKDC1TLR9TP53
SCHEMBL12767606 0.72 RAB9A (0.54) NSD2HSP90AA1HKDC1TLR9TP53
SCHEMBL28393851 0.72 TLR8 (0.50) TLR8RAB9AIDO1
SCHEMBL1802680 0.72 NSD2 (0.73) NSD2HSP90AA1HKDC1TLR9MAOB
SCHEMBL14199687 0.71 SOD1 (0.37) TLR8ALDH1A1POLBIDO1SOD1
SCHEMBL14228033 0.71 TLR8 (0.34) TLR8KDM4ECYP1A2POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2000456-A9 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2009-04-08 — — EP disclosed
EP-2000456-A2 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-12-10 — — EP disclosed
US-20080093985-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-04-24 — — US disclosed
US-20080093985-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080093985-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NDUFS7, NDUFA9, NDUFS8 NSD2 1941/4885HSP90AA1 4258/4885HKDC1 2778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback